TuHURA CFO Buys 274,000 Options Amid Surge in Insider Activity, Signals Confidence in Biotech Pipeline
TuHURA CFO’s fresh 273k‑option buy shows insider confidence amid a 84% dip—could signal a rebound as clinical milestones progress.
3 minutes to read